Dr. Vin Gupta: Blood clots from J&J vaccine ‘exceptionally rare’
04:22
Share this -
copied
Federal health authorities recommended that providers temporarily stop administering the Johnson & Johnson Covid-19 vaccine while they investigate a potential link to very rare blood clots. Six women between the ages of 18 and 48 developed blood clots after receiving the Johnson & Johnson vaccine and the clots are considered extremely rare. This is out of the more than 6.8 million people in the U.S. have received the Johnson & Johnson vaccine. Dr. Vin Gupta calls this "exceptionally rare, lower than the background rate ... It's to alert folks like myself and my colleagues that this is happening, extremely rarely, but this needs to be treated differently than what you treat a blood clot."April 14, 2021
UP NEXT
Murdoch 'literally wishes Trump dead’ Michael Wolff alleges in his new book on Fox family dynasty
07:02
‘Trump is running for retribution’: Schmidt warns Trump will avenge ‘anybody who was against him’
09:54
‘It’s going to save lives’: Frost on sparking first White House Office of Gun Violence Prevention
06:52
'DOJ and Congress need to investigate this man': Expert calls for ethics probe into Clarence Thomas
10:34
‘It’s radical, reckless, ridiculous’: Veteran slams Tuberville’s blockade of military promotions
05:58
'Dangerous for America': Warren slams GOP enabling Tuberville to block critical military promotions